(精选)【医学课件课件】Treating Diabetic Cystoid Macular Edema with Intravitreal Triamcinolone Pars Plana Steroid Implant教学课件.pptVIP

Treating Diabetic Cystoid Macular Edema with Intravitreal Triamcinolone Pars Plana Steroid Implant治疗糖尿病性黄斑囊样水肿玻璃体内注射去炎松经平坦部植入类固醇植入体;Acknowledgement 致谢;Diabetes: very common糖尿病：非常普遍的疾病;DME is a major problem!黄斑水肿：视力受损的主要难题;Conventional DME treatment常规糖尿病黄斑水肿的治疗;Conventional DME treatment常规糖尿病黄斑水肿的治疗新方法;Is there an alternative?有替代治疗方法吗？;Pathogenesis 发病机制;Pathogenesis of DME糖尿病黄斑水肿的发病机制;Pathogenesis of DME糖尿病黄斑水肿的发病机制;Role of corticosteroids皮质类固醇的作用;Intravitreal Triamcinolone玻璃体内注射去炎松 ;Possible usages 可能的用途;Treatment of DME糖尿病黄斑水肿的治疗;Treatment of DME糖尿病黄斑水肿的治疗;Treating DME with ivTA用ivTA治疗糖尿病黄斑水肿;Our experience 我们的经验;Our experience我们的经验;Our experience我们的经验;IvTA alone 单纯TA注药;Practical tips - Shake before use!;Practical tips 操作技巧 ;Practical tips 操作技巧;Preparation;Preparation;Video of ivTA injection;With simultaneous Phaco IOL;Results 结果 ;Visual Acuity Change;Error bars show standard error of the mean;Change in macular edema after ivTA (6-month data) TA注射后三个月内，黄斑水肿的改变 ;Our experience 我们的经验 ;Case: LYL OD 病例报告：LYL右眼 ;Case: LYL OS 病例报告：LYL左眼 (Thickened posterior hyaloid face);Poor prognostic factors;Poor prognostic factors;Subgroup analysis (VA);Subgroup Analysis (Macular thickness on OCT);Poor prognostic factors;Adverse events 不利的方面 ;Adverse events 不利的方面 ;Adverse events 不利的方面 ;Limitations of ivTA iVTA治疗的局限性;Limitations of ivTA iVTA治疗的局限性;In-vitro evidence 离体实验证据 ;In vitro evidence离体实验证据;Is there an another alternative?有无变通之处?;Pars plana steroid implant睫状部平坦部的激素植入物 ;Our experience 我们的经验;Implant procedure 植入手术 ;Preliminary results;6 months;596;Examples;Change in macular thickness;Change in Visual Acuity;Major Complications;Take Home Messages 回家思考的内容 ;Take Home Messages 回家思考的内容;